Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China flag China · Delayed Price · Currency is CNY
63.45
+0.38 (0.60%)
At close: Nov 17, 2026

Shanghai OPM Biosciences Revenue

Shanghai OPM Biosciences had revenue of 285.05M CNY in the quarter ending September 30, 2026, with 203.96% growth. This brings the company's total for the last twelve months to 822.13M, up 132.96% year-over-year. In the year 2025, Shanghai OPM Biosciences had annual revenue of 354.91M with 19.40% growth. That makes Shanghai OPM Biosciences the 21,157th largest company in the world by revenue and 3,880th in China.

Revenue (ttm)
822.13M
Revenue Growth
+132.96%
P/S Ratio
10.93
Revenue / Employee
8.06M
Employees
102
Market Cap
9.04B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Culture Medium Products 300.45M 84.8%
  • CDMO 53.98M 15.2%

By Geography

Chart
  • China 244.92M 69.1%
  • Overseas 109.51M 30.9%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025354.91M57.67M19.40%
Dec 31, 2024297.24M54.12M22.26%
Dec 31, 2023243.12M-51.24M-17.41%
Dec 31, 2022294.37M81.68M38.41%
Dec 31, 2021212.68M87.71M70.19%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.